Cargando…
Overview: an iPS cell stock at CiRA
Induced pluripotent stem cells (iPSCs) can be produced from various somatic cells and have the ability to differentiate into various cells and tissues of the body. Regenerative medicine using iPSCs is expected to manage diseases lacking effective treatments at present. We are establishing a safe and...
Autores principales: | Umekage, Masafumi, Sato, Yoshiko, Takasu, Naoko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717959/ https://www.ncbi.nlm.nih.gov/pubmed/31497180 http://dx.doi.org/10.1186/s41232-019-0106-0 |
Ejemplares similares
-
iPS cells generation: an overview of techniques and methods
por: Telpalo-Carpio, SA, et al.
Publicado: (2013) -
iPS Cells—The Triumphs and Tribulations
por: Sharma, Riddhi
Publicado: (2016) -
Modeling Kidney Disease with iPS Cells
por: Freedman, Benjamin S.
Publicado: (2015) -
Aging in iPS cells
por: Miller, Justine, et al.
Publicado: (2014) -
Drug-Induced Naïve iPS Cells Exhibit Better Performance than Primed iPS Cells with Respect to the Ability to Differentiate into Pancreatic β-Cell Lineage
por: Kiyokawa, Yuki, et al.
Publicado: (2020)